Chemoinformaics analysis of Methyl propyl pentasulfide
| Molecular Weight | 218.459 | nRot | 6 |
| Heavy Atom Molecular Weight | 208.379 | nRig | 0 |
| Exact Molecular Weight | 217.939 | nRing | 0 |
| Solubility: LogS | -5.109 | nHRing | 0 |
| Solubility: LogP | 2.107 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 27.8479 |
| nHD | 0 | BPOL | 12.4921 |
| QED | 0.478 |
| Synth | 4.05 |
| Natural Product Likeliness | 1.851 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -4.888 |
| MDCK | 0.0000238 |
| BBB | 0.968 |
| PPB | 0.478319 |
| VDSS | 1.058 |
| FU | 0.364255 |
| CYP1A2-inh | 0.913 |
| CYP1A2-sub | 0.913 |
| CYP2c19-inh | 0.993 |
| CYP2c19-sub | 0.896 |
| CYP2c9-inh | 0.878 |
| CYP2c9-sub | 0.803 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.284 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.239 |
| CL | 8.979 |
| T12 | 0.06 |
| hERG | 0.344 |
| Ames | 0.751 |
| ROA | 0.549 |
| SkinSen | 0.968 |
| Carcinogencity | 0.21 |
| EI | 0.995 |
| Respiratory | 0.988 |
| NR-Aromatase | 0.377 |
| Antiviral | No |
| Prediction | 0.947582 |